))
Defining MS Subtypes in Clinical Practice
Manage episode 407345640 series 3559522
内容由European Committee for Treatment and Research in Multiple Sclerosis, The European Committee for Treatment, and Research in Multiple Sclerosis提供。所有播客内容（包括剧集、图形和播客描述）均由 European Committee for Treatment and Research in Multiple Sclerosis, The European Committee for Treatment, and Research in Multiple Sclerosis 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Descriptors of multiple sclerosis are currently based on a combination of clinical and MRI features, and include clinically isolated syndrome, relapsing-remitting, secondary and primary progressive subtypes. Accumulating evidence suggests that the clinical course of MS is better considered as a continuum, with contributions from concurrent pathophysiological processes that vary across individuals and over time. In this episode, MS Journal Editor in Chief Alan Thompson talks with neurologists Marcello Moccia of the Multiple Sclerosis Unit of the University of Naples Federico II and Angela Vidal of Centre d’Esclerosi Multiple de Catalunya on the new understanding of the key mechanisms underlying progression and the availability of neuroimaging and humoral biomarkers and their implications for clinical care and treatment.
35集单集
分享
